Panagora Asset Management’s Lifecore Biomedical LFCR Stock Holding History

Panagora Asset Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,112	Closed	-$24K	–	2080
2021 Q2	$24K	Sell	2,112 -7,833	-79%	-$90.3K	﹤0.01%	2147
2021 Q1	$105K	Hold	9,945	–	–	﹤0.01%	1993
2020 Q4	$108K	Hold	9,945	–	–	﹤0.01%	1816
2020 Q3	$97K	Sell	9,945 -3,103	-24%	-$29.6K	﹤0.01%	1805
2020 Q2	$104K	Buy	+13,048	New	+$135K	﹤0.01%	1777
2017 Q3	–	Sell	-9,714	Closed	-$144K	–	2418
2017 Q2	$144K	Buy	9,714 +729	+8%	+$10.1K	﹤0.01%	1766
2017 Q1	$107K	Hold	8,985	–	–	﹤0.01%	1843
2016 Q4	$124K	Hold	8,985	–	–	﹤0.01%	1887
2016 Q3	$120K	Hold	8,985	–	–	﹤0.01%	1918
2016 Q2	$97K	Hold	8,985	–	–	﹤0.01%	1923
2016 Q1	$94K	Hold	8,985	–	–	﹤0.01%	1872
2015 Q4	$106K	Hold	8,985	–	–	﹤0.01%	1781
2015 Q3	$105K	Sell	8,985 -20,496	-70%	-$272K	﹤0.01%	1805
2015 Q2	$425K	Hold	29,481	–	–	﹤0.01%	1396
2015 Q1	$410K	Sell	29,481 -9,060	-24%	-$125K	﹤0.01%	1399
2014 Q4	$532K	Hold	38,541	–	–	﹤0.01%	1258
2014 Q3	$472K	Sell	38,541 -16,708	-30%	-$209K	﹤0.01%	1329
2014 Q2	$689K	Hold	55,249	–	–	﹤0.01%	1262
2014 Q1	$616K	Sell	55,249 -45,326	-45%	-$497K	﹤0.01%	1355
2013 Q4	$1.22M	Buy	100,575 +171	+0.2%	+$2.04K	0.01%	1093
2013 Q3	$1.23M	Buy	100,404 +1,267	+1%	+$17.7K	0.01%	1034
2013 Q2	$1.31M	Buy	+99,137	New	+$1.37M	0.01%	956

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Panagora Asset Management's LFCR Position: Q3 2021 in Review

Panagora Asset Management sold out of Lifecore Biomedical (LFCR) in Q3 2021, closing a stake of 2,112 shares — an estimated $24K sold.

Panagora Asset Management first reported a position in LFCR in Q2 2013 and held it in 22 quarters. The position peaked at $1.31M in Q2 2013. 92 funds tracked by Wall St. Rank hold LFCR as of Q3 2021.

Panagora Asset Management reported no remaining Lifecore Biomedical position as of Q3 2021 after selling out during the quarter.
Panagora Asset Management sold 2,112 Lifecore Biomedical shares in Q3 2021, an estimated $24K.
Panagora Asset Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 22 quarters.
Panagora Asset Management's Lifecore Biomedical position peaked at $1.31M in Q2 2013.
92 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.